Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $6.03B.
ENTERPRISE VALUE (EV)
$6.03B
CG Oncology Inc.
Market Cap
$6.06B
Enterprise Value (EV)
$6.03B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| CG Oncology Inc. (CGON) | $6.06B | $6.03B |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.50B | $9.16B |
| CRISPR Therapeutics AG (CRSP)vs › | $5.53B | $6.02B |
| GRAIL Inc. (GRAL)vs › | $6.61B | $6.65B |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.62B | $7.56B |
| Chemed Corporation (CHE)vs › | $6.68B | $6.97B |
| Doximity, Inc. (DOCS)vs › | $5.35B | $5.08B |
| Cogent Biosciences, Inc. (COGT)vs › | $5.27B | $5.34B |
| Immunovant, Inc. (IMVT)vs › | $6.86B | $6.07B |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | $5.57B |
Market Cap
$6.06B
Total Debt
$3.00M
Cash
$32.49M
Enterprise Value
$6.03B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
